KRAS and neoplasm: We show that oncogenic MAPK signalling induces epithelial-state changes in vivo, driving adoption of a regenerative/revival stem-like population, whereas inhibition leads to rapid transcriptional remodelling of both Kras-mutant and Braf-mutant tumours, favouring a WNT-associated, canonical stem phenotype.